A scoping review of the public health impact of vitamin D-fortified dairy products for fracture prevention

Archives of Osteoporosis

Volumn 12, Issue 1, 2017, Pages

  Hiligsmann, Mickael ^a   Neuprez, Audrey ^b   Buckinx, Fanny ^b   Locquet, Médéa ^b   Reginster, Jean Yves ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cost effectiveness; Dairy products; Fractures; Nutrition; Osteoporosis; Public health

Indexed keywords

CALCIUM; VITAMIN D;

CARDIOVASCULAR EFFECT; COST EFFECTIVENESS ANALYSIS; DAIRY PRODUCT; ECONOMIC ASPECT; FRAGILITY FRACTURE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; CALCIUM INTAKE; COST BENEFIT ANALYSIS; ECONOMICS; FORTIFIED FOOD; PROCEDURES; PUBLIC HEALTH;

CALCIUM, DIETARY; COST-BENEFIT ANALYSIS; DAIRY PRODUCTS; FOOD, FORTIFIED; HUMANS; OSTEOPOROTIC FRACTURES; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; VITAMIN D;

EID: 85021375174     PISSN: 18623522     EISSN: 18623514     Source Type: Journal    
DOI: 10.1007/s11657-017-0352-1     Document Type: Review

References (26)

1. Avenell A, Mak JC, O'Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 4:CD000227
2. Al-Daghri NM, Al-Saleh Y, Aljohani N, Sulimani R, Al-Othman AM, Alfawaz H et al (2017) Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO). Arch Osteoporos 12(1):1
3. Harvey NC, Biver E, Kaufman JM, Bauer J, Branco J, Brandi ML et al (2017) The role of calcium supplementation in healthy musculoskeletal ageing: an expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos Int 28(2):447–462
4. Rizzoli R, Boonen S, Brandi ML, Bruyere O, Cooper C, Kanis JA et al (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29(4):305–313
5. Rizzoli R, Stevenson JC, Bauer JM, van Loon LJ, Walrand S, Kanis JA et al (2014) The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas 79(1):122–132
6. Rozenberg S, Body JJ, Bruyere O, Bergmann P, Brandi ML, Cooper C et al (2016) Effects of dairy products consumption on health: benefits and beliefs—a commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Calcif Tissue Int 98(1):1–17
7. Bruyere O, De Cock C, Mottet C, Neuprez A, Malaise O, Reginster JY (2009) Low dietary calcium in European postmenopausal osteoporotic women. Public Health Nutr 12(1):111–114
8. Bruyere O, Slomian J, Beaudart C, Buckinx F, Cavalier E, Gillain S et al (2014) Prevalence of vitamin D inadequacy in European women aged over 80 years. Arch Gerontol Geriatr 59(1):78–82
9. Fardellone P, Cotte FE, Roux C, Lespessailles E, Mercier F, Gaudin AF (2010) Calcium intake and the risk of osteoporosis and fractures in French women. Joint, bone, spine: revue du rhumatisme 77(2):154–158
10. Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY (2008) The role of calcium and vitamin D in the management of osteoporosis. Bone 42(2):246–249
11. Rizzoli R (2014) Dairy products, yogurts, and bone health. Am J Clin Nutr 99(5 Suppl):1256S–1262S
12. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57
13. Hiligsmann M, Kanis JA, Compston J, Cooper C, Flamion B, Bergmann P et al (2013) Health technology assessment in osteoporosis. Calcif Tissue Int 93(1):1–14
14. Borgstrom F, Johnell O, Kanis JA, Jonsson B, Rehnberg C (2006) At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17(10):1459–1471
15. Lippuner K, Johansson H, Borgstrom F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX(R) in Switzerland. Osteoporos Int 23(11):2579–2589
16. Marques A, Lourenco O, Ortsater G, Borgstrom F, Kanis JA, da Silva JA (2016) Cost-effectiveness of intervention thresholds for the treatment of osteoporosis based on FRAX((R)) in Portugal. Calcif Tissue Int 99(2):131–141
17. Ethgen O, Hiligsmann M, Burlet N, Reginster JY (2015) Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Archives of public health 73:48
18. Ethgen O, Hiligsmann M, Burlet N, Reginster JY (2016) Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporos Int 27(1):301–308
19. Hagen G, Wisloff T, Kristiansen IS (2016) The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects. Osteoporos Int 27(6):2089–2098
20. Hiligsmann M, Ben Sedrine W, Bruyere O, Evers SM, Rabenda V, Reginster JY (2015) Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. Eur J Pub Health 25(1):20–25
21. Hiligsmann M, Burlet N, Fardellone P, Al-Daghri N, Reginster JY (2017) Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France. Osteoporos Int 28(3):833–840
22. Lotters FJ, Lenoir-Wijnkoop I, Fardellone P, Rizzoli R, Rocher E, Poley MJ (2013) Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products. Osteoporos Int 24(1):139–150
23. Sandmann A, Amling M, Barvencik F, Konig HH, Bleibler F (2015) Economic evaluation of vitamin D and calcium food fortification for fracture prevention in Germany. Public Health Nutr:1–10
24. Hiligsmann M, Ethgen O, Bruyere O, Richy F, Gathon HJ, Reginster JY (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 12(5):687–696
25. Briot K, Maravic M, Roux C (2015) Changes in number and incidence of hip fractures over 12 years in France. Bone 81:131–137
26. Sandmann A, Brown J, Mau G, Saur M, Amling M, Barvencik F (2015) Acceptance of vitamin D-fortified products in Germany—a representative consumer survey. Food Qual Prefer 43:53–62